Search results
Added:
9 months ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed…
View more
Added:
8 months ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best…
View more
Added:
1 month ago
Added:
2 months ago
EHRA 2025 - Outcomes from model screening for atrial fibrillation (AF) show the combination of a risk prediction model and long-term electrocardiogram (ECG) monitoring is superior to standard of care in detecting new cases of AF in a high-risk population aged 65 years or older. In the risk prediction model arm, the incidence of AF after six months was significantly higher than the incidence in…
View more
Added:
9 months ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East…
View more
Added:
5 months ago
AF Symposium 25 - The MANIFEST-REDO sub-study suggests repeat ablation procedures due to clinical recurrence of atrial fibrillation (AF) can be performed safely and with an acceptable success rate.Prof Daniel Scherr (Medical University, Graz, AT) joins us onsite at AF Symposium 25 to discuss the insights from MANIFEST-REDO, investigating repeated ablation following pulmonary vein isolation (PVI)…
View more
Added:
4 months ago
Added:
10 months ago
Added:
9 months ago
Added:
1 year ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial.
FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists …
View more
